Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arformoterol in acute asthma
NCT00819637Phase 4Terminated
- Sponsor
- Henry Ford Health
- Start
- Jan 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arformoterol in asthma, sponsored by Henry Ford Health. Started Jan 2009; status: terminated.
02
Drugs
arformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00819637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819637.